Transcriptome analysis of a CHO cell line expressing a recombinant therapeutic protein treated with inducers of

Dina Fomina-Yadlin1, Mirna Mujacic1, Kathy Maggiora1

  • 1Drug Substance Development, Amgen Inc., Seattle, WA 98119, United States.

Journal of Biotechnology
|September 2, 2015
PubMed

Related Concept Videos